Increased Prevalence of HPV for Men With Phimosis

This article originally appeared here.
Share this content:
Increased Prevalence of HPV for Men With Phimosis
Increased Prevalence of HPV for Men With Phimosis

THURSDAY, June 16, 2016 (HealthDay News) -- Men with phimosis have increased prevalence of human papillomavirus (HPV) and high-risk HPV genotypes compared with asymptomatic men, according to a study published in the June issue of The Journal of Urology.

Larissa A. Afonso, Ph.D., from the Universidade Federal Fluminense in Rio de Janeiro, and colleagues examined the incidence of HPV infection in 110 asymptomatic men and 30 patients who underwent circumcision due to phimosis. DNA was extracted from swabbed samples from asymptomatic men and from foreskin samples obtained at circumcision in men with phimosis.

The researchers found that 46.66 percent of patients with phimosis had HPV, of whom 50 percent had high-risk HPV genotypes. Overall, 16.36 percent of the asymptomatic cases were HPV positive; high-risk HPV was seen in only one sample. Patients presenting with phimosis had a significantly higher rate of HPV genital infection than asymptomatic men (P = 0.00167). Patients with phimosis had significantly higher prevalence of high-risk HPV genotypes (P = 0.004).

"We found a robust association between phimosis and the genital HPV prevalence in men and a significant frequency of high-risk HPV," the authors write. "Other studies are needed to investigate the occurrence of factors that can increase the incidence of penile carcinoma and determine its impact on female genital infection in cervical cancer."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »